Liam Kenyon

Director Talent Acquisition @Autolus Therapeutics

London, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2024 — Present

Director Talent Acquisition @Autolus Therapeutics

View department →

London, GB

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies. The company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognise cancer cells, break down their defence mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of haematological malignancies and solid tumours.

EDUCATION

N/A

Carmel College

A-Level, Psychology A; Philosophy A, Biology A

2007 — 2010

University of Liverpool

BA(Hons) 2:1, Philosophy

SKILLS

ManagementChange ControlCRORegulatory AffairsLifesciencesHealthcareResearchGmpChromatographyCell BiologyValidationScienceBiochemistryTelephone InterviewingRegulatory RequirementsOncologyAuditingProbeIntellectual PropertyGlpGxpQuality AuditingPharmaceutical IndustrySopFdaMicrobiologyQuality AssuranceRecruitingR&DClinical DevelopmentHplcQuality SystemMolecular BiologyPatentsHeadhuntDrug DevelopmentGcpBiopharmaceuticalsBiotechnologyTechnology Transfer

ABOUT LIAM KENYON

A Talent Acquisition professional with 12+ years of supporting growth in the Biotech space - with a particular focus on Cell & Gene Therapy.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Liam Kenyon — Director Talent Acquisition at Autolus Therapeutics in London, GB | Unifers